BMJ 1995;310:817-818 (1 April)
Editorials
Non-steroidal anti-inflammatory drugs and elderly patients
The medicine may be worse than the disease
Aches and pains are a feature of growing old, but managing these symptoms in elderly people can pose problems. Patients have often used paracetamol and aspirin, which are available over the counter without prescription, before consultation. Opiates cause constipation and non-steroidal anti-inflammatory drugs cause ulcers. Although these associations are well known, 20 million prescriptions for non-steroidal anti-inflammatory drugs (many for elderly people) were dispensed in 1993 in Britain, at a cost of over pounds sterling180m.1
Several factors affect the relative risk of adverse gastrointestinal effects during treatment with non-steroidal anti-inflammatory drugs. These include the age of the patient2 3 4 5 6 7 8; their medical history3 4 6 7; the drug used and its dosage4 9; its route of administration10 and the duration of treatment3 4 8; the concomitant use of more than one such drug4; and other independent risk factors, particularly alcohol use, anti-coagulant treatment, corticosteroid treatment, . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option
- Michael R Lewis and Diana Kay
BMJ 2005 331: 1474.
[Extract]
[Full Text]
-
Non-steroidal anti-inflammatory drugs in elderly people
- Adrian H Hopper
BMJ 1995 311: 391.
[Extract]
[Full Text]
-
Enteric coated aspirin may reduce risk
- Charles M Grossman
BMJ 1995 311: 391.
[Extract]
[Full Text]
-
Gastrointestinal bleeding is common
- Joan-Ramon Laporte, Xavier Vidal, and Xavier Carne
BMJ 1995 311: 391.
[Extract]
[Full Text]
-
Mefenamic acid is more dangerous than most
- David J Grant and A M Macconnachie
BMJ 1995 311: 392.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Lewis, M. R, Kay, D.
(2005). Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option. BMJ
331: 1474-1474
[Full text]
-
Predel, H G, Koll, R, Pabst, H, Dieter, R, Gallacchi, G, Giannetti, B, Bulitta, M, Heidecker, J L, Mueller, E A
(2004). Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br. J. Sports. Med.
38: 318-323
[Abstract]
[Full text]
-
Moore, R A, Tramèr, M R, Carroll, D, Wiffen, P J, McQuay, H J
(1998). Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ
316: 333-338
[Abstract]
[Full text]
-
Pace, V.
(1995). Use of nonsteroidal anti-inflammatory drugs in cancer. Palliat Med
9: 273-286
[Abstract]
-
Dieppe, P.
(1995). Fortnightly Review: Management of hip osteoarthritis. BMJ
311: 853-857
[Abstract]
[Full text]
-
Grant, D. J, Macconnachie, A M
(1995). Mefenamic acid is more dangerous than most. BMJ
311: 392-392
[Full text]
-
Hopper, A. H
(1995). Non-steroidal anti-inflammatory drugs in elderly people. BMJ
311: 391b-391
[Full text]
-
Grossman, C. M
(1995). Enteric coated aspirin may reduce risk. BMJ
311: 391c-391
[Full text]
-
Laporte, J.-R., Vidal, X., Carne, X.
(1995). Gastrointestinal bleeding is common. BMJ
311: 391d-391
[Full text]